IDEX Corporation Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw 5% organic sales growth and 10% order growth, led by HST's strong performance. Full-year guidance was raised, with robust backlog and continued capital deployment supporting growth, while macro uncertainty keeps FMT and FSDP outlooks conservative.
-
Phase three is at its midpoint, with strong HST growth, ongoing M&A, and a focus on digital and AI transformation. Capital deployment balances bolt-on acquisitions and share repurchases, while global expansion leverages localized operations. HST leads growth, FMT and FSDP remain stable, and innovation is driven by applying core technologies to new markets.
Fiscal Year 2025
-
Q4 2025 saw organic sales and margin growth, led by HST's strong order momentum in data centers and semiconductors. 2026 guidance calls for 1%-2% organic growth, margin expansion, and continued capital deployment to M&A and share repurchases, with HST expected to outperform other segments.
-
Q3 2025 results exceeded expectations with 5% organic revenue growth and strong performance in HST and FMT segments, while FSDP remained soft. Full-year guidance was narrowed, with continued focus on bolt-on M&A, cost optimization, and shareholder returns amid ongoing macro uncertainty.
-
Q2 results exceeded expectations despite macro uncertainty, with strong performance in pharma, energy, data centers, and defense, but softness in auto, chemicals, and semiconductor lithography. Full-year guidance was lowered due to slower customer decision-making and policy-driven order delays, especially in recently acquired businesses. Free cash flow and liquidity remain strong.
-
Q1 2025 results exceeded expectations with record orders and strong performance in key markets, despite a 1% organic sales decline. Full-year guidance is maintained, with proactive cost savings and price actions set to offset tariff impacts and potential volume pressures.
Fiscal Year 2024
-
Q4 and full-year results showed resilient performance amid macro uncertainty, with strong orders, record sales in Fire & Safety, and successful Mott integration. 2025 guidance calls for 1%-3% organic growth, margin expansion, and EPS growth, with HST leading segment recovery and benefits from platform optimization.
-
Q3 delivered stable order rates, strong free cash flow, and margin expansion in key segments. HST orders surged, Mott integration advanced, and guidance for Q4 and full year remains steady despite macro uncertainty and delayed semiconductor recovery.
-
Q2 results met expectations with stable core demand but project delays due to macro and political uncertainty. Guidance for 2024 was revised downward, with revenue now expected to decline 1%-2% and adjusted EPS lowered. Recent acquisitions and innovation support long-term growth.
-
The acquisition targets a leader in precision filtration, expanding access to high-growth markets and leveraging complementary expertise. The $1B deal is expected to be accretive to EPS by 2026, with significant margin expansion and synergies anticipated through operational excellence and integration.